Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	247	242	124	53	49	155
Market Cap Growth	-6.67%	95.09%	134.61%	7.07%	-68.06%	-43.37%
Enterprise Value	64	156	76	43	-11	67
Last Close Price	4.55	5.57	5.01	3.08	8.43	39.25
PS Ratio	616.43	-	35.46	37.41	16.47	15.47
PB Ratio	1.39	5.50	8.37	1.98	1.17	1.51
P/TBV Ratio	1.44	5.50	8.37	1.98	1.21	2.26
EV/Sales Ratio	158.90	-	21.73	30.43	-	6.68
Debt / Equity Ratio	0.14	0.52	0.36	0.28	0.22	0.09
Asset Turnover	0.00	-	0.06	0.02	0.03	0.05
Quick Ratio	9.41	5.99	4.07	6.73	2.89	2.27
Current Ratio	9.74	6.08	4.15	6.83	3.39	2.33
Return on Equity (ROE)	75.90%	-216.57%	-260.60%	-114.85%	-117.22%	-59.96%
Return on Assets (ROA)	-29.58%	-46.41%	-46.99%	-39.34%	-31.07%	-16.19%
Return on Capital (ROIC)	-39.37%	-91.94%	-110.32%	-65.68%	-43.99%	-20.37%
Return on Capital Employed (ROCE)	-39.80%	-69.50%	-95.30%	-80.20%	-91.10%	-44.40%
Earnings Yield	33.40%	-26.32%	-43.66%	-75.04%	-171.90%	-54.45%
FCF Yield	-33.40%	-24.14%	-30.09%	-82.44%	-141.30%	-23.50%
Buyback Yield / Dilution	-74.23%	-91.99%	-171.96%	-99.65%	-6.24%	-84.02%

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q